Fund Overview of Quant Healthcare Fund Regular - Idcw
-
₹409.2 CrAUM
-
₹15.50NAV
-
2.40%Expense Ratio
-
EquityFund Category
Returns of Quant Healthcare Fund Regular - Idcw
| Tenure | Absolute(%) | Annualised(%) | Category Average(%) |
|---|---|---|---|
| 3 Months | 0.19% | NA | 6.12% |
| 6 Months | 16.57% | NA | 12.92% |
| 1 Year | -9.55% | -9.55% | 6.04% |
| 2 Years | 46.55% | 21.06% | 24.93% |
Asset Allocation
equities
97.45%debt instruments
6.21%Quant Healthcare Fund Regular - Idcw is one Equity mutual fund offered by Quant Mutual Fund. Launched on 17 Jul 2023, the fund aims Capital appreciation over long term. Equity Investments in stocks of companies in the healthcare sector. It manages assets worth ₹409.2 crore as on Thu Jul 31, 2025. The expense ratio stands at 2.4%. Fund Manager Manager Education Fund Manager Manager Education Fund Manager Manager Education Fund Manager Manager Education Fund Manager Manager Education Fund Manager Manager Education Fund Manager Manager EducationAbout Quant Healthcare Fund Regular - Idcw
The portfolio allocation consists of 97.45% in equities, 6.21% in debt instruments. Managed by Ankit A Pande, it has delivered a return of -9.55% in the last year, a total return since inception of 22.08%.
Fund Details
|
|
Top Performing Mutual Funds
| Fund Names | AUM (Cr) | 1M | 3M | 1Yr | 3Yr | 5Yr |
|---|---|---|---|---|---|---|
| ICICI Prudential Pharma Healthcare And Diagnostics (p.h.d) Fund Direct - Growth |
₹6,104 | 0.21% | 0.48% | 9.03% | 28.99% | 21.62% |
| ICICI Prudential Pharma Healthcare And Diagnostics (p.h.d) Fund - Growth |
₹6,104 | 0.12% | 0.25% | 8.10% | 27.87% | 20.55% |
| Aditya Birla Sun Life Pharma & Healthcare Fund Direct-growth |
₹872 | -0.03% | -1.35% | 5.10% | 23.18% | 17.50% |
| Aditya Birla Sun Life Pharma & Healthcare Fund Regular-growth |
₹872 | -0.13% | -1.67% | 3.76% | 21.53% | 15.83% |
More funds from Quant Mutual Fund
| Fund Names | AUM (Cr) | 1M | 3M | 6M | 1Yr | 3Yr |
|---|---|---|---|---|---|---|
|
Quant Healthcare Fund Regular - Growth
|
₹409 | -0.03% | 1.53% | 0.79% | -1.60% | - |
|
Quant Healthcare Fund Direct - Growth
|
₹409 | 0.12% | 1.94% | 1.62% | 0.02% | - |
|
Quant Healthcare Fund Direct - Idcw
|
₹409 | 0.12% | 1.94% | 1.62% | 0.02% | - |
Mutual Fund Calculator
- 1
- 2
- 3
- 4
- 6
- 7
- 8
- 9
- 11
- 12
- 13
- 14
- 16
- 17
- 18
- 19
- 21
- 22
- 23
- 24
- 26
- 27
- 28
- 29
- 31
- 32
- 33
- 34
- 36
- 37
- 38
- 39
- 40
- 1
- 2
- 3
- 4
- 6
- 7
- 8
- 9
- 11
- 12
- 13
- 14
- 16
- 17
- 18
- 19
- 21
- 22
- 23
- 24
- 26
- 27
- 28
- 30
- 1
- 2
- 3
- 4
- 6
- 7
- 8
- 9
- 11
- 12
- 13
- 14
- 16
- 17
- 18
- 19
- 21
- 22
- 23
- 24
- 26
- 27
- 28
- 29
- 31
- 32
- 33
- 34
- 36
- 37
- 38
- 39
- 40
- 1
- 2
- 3
- 4
- 6
- 7
- 8
- 9
- 11
- 12
- 13
- 14
- 16
- 17
- 18
- 19
- 21
- 22
- 23
- 24
- 26
- 27
- 28
- 30
Top Mutual Funds
| Fund Names | AUM (Cr) | NAV | 3Yr | 5Yr | 10Yr |
|---|---|---|---|---|---|
| ICICI Prudential Pharma Healthcare And Diagnostics (p.h.d) Fund - Growth |
₹6,104 | ₹40.45 | 27.87% | 20.55% | - |
| ICICI Prudential Pharma Healthcare And Diagnostics (p.h.d) Fund Direct - Growth |
₹6,104 | ₹43.71 | 28.99% | 21.62% | - |
| Aditya Birla Sun Life Pharma & Healthcare Fund Direct-growth |
₹872 | ₹34.41 | 23.18% | 17.50% | - |
| Aditya Birla Sun Life Pharma & Healthcare Fund Regular-growth |
₹872 | ₹31.21 | 21.53% | 15.83% | - |
| ICICI Prudential Nifty Healthcare Etf - Growth |
₹146 | ₹152.37 | 22.80% | - | - |
| Aditya Birla Sun Life Nifty Healthcare Etf-growth |
₹37 | ₹15.28 | 22.97% | - | - |
Detailed Portfolio
| Stocks | Sector | % of Holding | Value |
|---|---|---|---|
| Repo | Unspecified | 15.82% | ₹60.74 Cr |
| Repo | Unspecified | 15.82% | ₹60.74 Cr |
| Repo | Unspecified | 13.61% | ₹51.56 Cr |
| Repo | Unspecified | 11.42% | ₹46.75 Cr |
| Aster Dm Healthcare Ltd | Healthcare | 10.01% | ₹40.96 Cr |
| Aster Dm Healthcare Ltd | Healthcare | 10.37% | ₹39.30 Cr |
| Rpg Life Sciences Ltd | Healthcare | 8.83% | ₹36.14 Cr |
| Rpg Life Sciences Ltd | Healthcare | 8.88% | ₹33.63 Cr |
| Cipla_(25/11/2025) | Healthcare | 8.45% | ₹32.44 Cr |
| Cipla_(25/11/2025) | Healthcare | 8.45% | ₹32.44 Cr |
| Sequent Scientific Ltd | Healthcare | 8.26% | ₹31.70 Cr |
| Sequent Scientific Ltd | Healthcare | 8.26% | ₹31.70 Cr |
| Zydus Wellness Ltd | Consumer Staples | 7.97% | ₹30.58 Cr |
| Zydus Wellness Ltd | Consumer Staples | 7.97% | ₹30.58 Cr |
| Aster Dm Healthcare Ltd | Healthcare | 7.89% | ₹30.29 Cr |
| Aster Dm Healthcare Ltd | Healthcare | 7.89% | ₹30.29 Cr |
| Zydus Wellness Ltd | Consumer Staples | 7.74% | ₹29.34 Cr |
| Sequent Scientific Ltd | Healthcare | 7.26% | ₹27.52 Cr |
| Zydus Wellness Ltd | Consumer Staples | 6.36% | ₹26.04 Cr |
| Lupin Ltd. 25-nov-25 | Healthcare | 6.76% | ₹25.97 Cr |
| Lupin Ltd. 25-nov-25 | Healthcare | 6.76% | ₹25.97 Cr |
| Lupin_28/08/2025 | Healthcare | 6.21% | ₹25.41 Cr |
| Sequent Scientific Ltd | Healthcare | 6.21% | ₹25.40 Cr |
| Glenmark Life Sciences Ltd | Healthcare | 6.21% | ₹25.40 Cr |
| Anthem Biosciences Ltd. | Healthcare | 6.70% | ₹25.39 Cr |
| Lupin Ltd. 28-oct-25 | Healthcare | 6.68% | ₹25.30 Cr |
| Sms Pharmaceuticals Ltd | Healthcare | 6.53% | ₹25.06 Cr |
| Sms Pharmaceuticals Ltd | Healthcare | 6.53% | ₹25.06 Cr |
| Pfizer Ltd | Healthcare | 6.51% | ₹24.98 Cr |
| Pfizer Ltd | Healthcare | 6.51% | ₹24.98 Cr |
| Pfizer Ltd | Healthcare | 6.09% | ₹24.91 Cr |
| Aurobindo Pharma Ltd | Healthcare | 6.05% | ₹24.77 Cr |
| Aurobindo Pharma Ltd | Healthcare | 6.45% | ₹24.75 Cr |
| Aurobindo Pharma Ltd | Healthcare | 6.45% | ₹24.75 Cr |
| Anthem Biosciences Ltd. | Healthcare | 5.94% | ₹24.29 Cr |
| Pfizer Ltd | Healthcare | 6.37% | ₹24.15 Cr |
| Anthem Biosciences Ltd. | Healthcare | 6.17% | ₹23.69 Cr |
| Anthem Biosciences Ltd. | Healthcare | 6.17% | ₹23.69 Cr |
| Adani Enterprises Ltd | Materials | 6.14% | ₹23.57 Cr |
| Adani Enterprises Ltd | Materials | 6.14% | ₹23.57 Cr |
| Aurobindo Pharma Ltd | Healthcare | 6.22% | ₹23.55 Cr |
| Glenmark Life Sciences Ltd | Healthcare | 6.04% | ₹22.88 Cr |
| Hdfc Life Insurance Co Ltd | Financial | 5.94% | ₹22.50 Cr |
| Hdfc Life Insurance Co Ltd | Financial | 5.49% | ₹22.47 Cr |
| Glenmark Life Sciences Ltd | Healthcare | 5.80% | ₹22.28 Cr |
| Glenmark Life Sciences Ltd | Healthcare | 5.80% | ₹22.28 Cr |
| Sms Pharmaceuticals Ltd | Healthcare | 5.40% | ₹20.47 Cr |
| Sms Pharmaceuticals Ltd | Healthcare | 4.77% | ₹19.52 Cr |
| Hfcl Ltd | Technology | 4.41% | ₹18.06 Cr |
| Max Healthcare Institute Ltd | Healthcare | 4.30% | ₹17.62 Cr |
| Divi's Laboratories Ltd | Healthcare | 3.58% | ₹13.76 Cr |
| Divi's Laboratories Ltd | Healthcare | 3.58% | ₹13.76 Cr |
| Concord Biotech Ltd. | Healthcare | 3.63% | ₹13.75 Cr |
| Sun Pharmaceutical Industries Ltd | Healthcare | 3.22% | ₹13.18 Cr |
| Sun Pharmaceutical Industries Ltd | Healthcare | 3.40% | ₹13.06 Cr |
| Sun Pharmaceutical Industries Ltd | Healthcare | 3.40% | ₹13.06 Cr |
| Aurobindo Pharma Ltd. 25-nov-25 | Healthcare | 3.29% | ₹12.62 Cr |
| Aurobindo Pharma Ltd. 25-nov-25 | Healthcare | 3.29% | ₹12.62 Cr |
| Sunpharma_(28/08/2025) | Healthcare | 3.05% | ₹12.48 Cr |
| Sun Pharmaceutical Industries Ltd | Healthcare | 3.25% | ₹12.32 Cr |
| Laxmi Dental Ltd. | Healthcare | 2.99% | ₹12.24 Cr |
| Concord Biotech Ltd. | Healthcare | 3.14% | ₹12.05 Cr |
| Concord Biotech Ltd. | Healthcare | 3.14% | ₹12.05 Cr |
| Sun Pharmaceutical Industries Ltd. 28-oct-25 | Healthcare | 3.09% | ₹11.69 Cr |
| Lupin Ltd | Healthcare | 2.91% | ₹11.19 Cr |
| Lupin Ltd | Healthcare | 2.91% | ₹11.19 Cr |
| Lupin Ltd | Healthcare | 2.69% | ₹10.99 Cr |
| Lupin Ltd | Healthcare | 2.87% | ₹10.89 Cr |
| Godrej Properties Ltd | Real Estate | 2.80% | ₹10.76 Cr |
| Godrej Properties Ltd | Real Estate | 2.80% | ₹10.76 Cr |
| Aurobindo Pharma Ltd. 28-aug-25 | Healthcare | 2.62% | ₹10.71 Cr |
| Dr. Reddy's Laboratories Ltd Futures | Healthcare | 2.49% | ₹10.19 Cr |
| Aurobindo Pharma Ltd. 28-oct-25 | Healthcare | 2.69% | ₹10.18 Cr |
| Government Of India 36514 091 Days Tbill 18dc25 Fv Rs 100 | Financial | 1.81% | ₹6.95 Cr |
| Government Of India 36514 091 Days Tbill 18dc25 Fv Rs 100 | Financial | 1.81% | ₹6.95 Cr |
| Government Of India 36514 091 Days Tbill 18dc25 Fv Rs 100 | Financial | 1.83% | ₹6.92 Cr |
| Biocon Ltd. 28-aug-25 | Healthcare | 1.37% | ₹5.61 Cr |
| Gland Pharma Ltd | Healthcare | 1.48% | ₹5.59 Cr |
| Gland Pharma Ltd | Healthcare | 1.41% | ₹5.42 Cr |
| Gland Pharma Ltd | Healthcare | 1.41% | ₹5.42 Cr |
| Government Of India 36004 091 Days Tbill 21ag25 Fv Rs 100 | Financial | 1.22% | ₹4.99 Cr |
| Government Of India 36098 091 Days Tbill 18sp25 Fv Rs 100 | Financial | 0.97% | ₹3.97 Cr |
| Government Of India 36335 091 Days Tbill 20nv25 Fv Rs 100 | Financial | 0.78% | ₹2.99 Cr |
| Government Of India 36335 091 Days Tbill 20nv25 Fv Rs 100 | Financial | 0.78% | ₹2.99 Cr |
| Government Of India 36026 091 Days Tbill 28ag25 Fv Rs 100 | Financial | 0.73% | ₹2.99 Cr |
| Government Of India 36369 091 Days Tbill 28nv25 Fv Rs 100 | Financial | 0.78% | ₹2.99 Cr |
| Government Of India 36369 091 Days Tbill 28nv25 Fv Rs 100 | Financial | 0.78% | ₹2.99 Cr |
| Government Of India 36402 091 Days Tbill 04dc25 Fv Rs 100 | Financial | 0.78% | ₹2.99 Cr |
| Government Of India 36402 091 Days Tbill 04dc25 Fv Rs 100 | Financial | 0.78% | ₹2.99 Cr |
| Government Of India 36335 091 Days Tbill 20nv25 Fv Rs 100 | Financial | 0.79% | ₹2.98 Cr |
| Government Of India 36114 091 Days Tbill 25sp25 Fv Rs 100 | Financial | 0.73% | ₹2.98 Cr |
| Government Of India 36369 091 Days Tbill 28nv25 Fv Rs 100 | Financial | 0.79% | ₹2.97 Cr |
| Government Of India 36571 091 Days Tbill 02jn26 Fv Rs 100 | Financial | 0.77% | ₹2.97 Cr |
| Government Of India 36571 091 Days Tbill 02jn26 Fv Rs 100 | Financial | 0.77% | ₹2.97 Cr |
| Government Of India 36402 091 Days Tbill 04dc25 Fv Rs 100 | Financial | 0.78% | ₹2.97 Cr |
| Government Of India 36626 091 Days Tbill 15jn26 Fv Rs 100 | Financial | 0.77% | ₹2.97 Cr |
| Government Of India 36626 091 Days Tbill 15jn26 Fv Rs 100 | Financial | 0.77% | ₹2.97 Cr |
| Government Of India 36063 091 Days Tbill 11sp25 Fv Rs 100 | Financial | 0.49% | ₹1.99 Cr |
| Government Of India 36643 091 Days Tbill 23jn26 Fv Rs 100 | Financial | 0.51% | ₹1.98 Cr |
| Government Of India 36643 091 Days Tbill 23jn26 Fv Rs 100 | Financial | 0.51% | ₹1.98 Cr |
| Government Of India 35672 182 Days Tbill 04sp25 Fv Rs 100 | Financial | 0.24% | ₹1.00 Cr |
| Government Of India 36041 091 Days Tbill 04sp25 Fv Rs 100 | Financial | 0.24% | ₹1.00 Cr |
| Net Payables | Unspecified | -12.40% | ₹-46.99 Cr |
| Net Payables | Unspecified | -15.36% | ₹-62.84 Cr |
| Net Payables | Unspecified | -19.48% | ₹-74.78 Cr |
| Net Payables | Unspecified | -19.48% | ₹-74.78 Cr |
Top Equity Funds
| Fund Names | NAV | 3Yr | 5Yr | 52 weeks high |
|---|---|---|---|---|
| ICICI Prudential Pharma Healthcare And Diagnostics (p.h.d) Fund Direct - Growth |
₹43.71 | 28.99% | 21.62% | 44.69 |
| ICICI Prudential Pharma Healthcare And Diagnostics (p.h.d) Fund - Growth |
₹40.45 | 27.87% | 20.55% | 41.47 |
| Aditya Birla Sun Life Pharma & Healthcare Fund Direct-growth |
₹34.41 | 23.18% | 17.50% | - |
| Aditya Birla Sun Life Pharma & Healthcare Fund Regular-growth |
₹31.21 | 21.53% | 15.83% | - |
Quant Healthcare Fund Regular - Idcw
What is the current AUM of Quant Healthcare Fund Regular - Idcw?
As of Thu Jul 31, 2025, Quant Healthcare Fund Regular - Idcw manages assets worth ₹409.2 crore
How has Quant Healthcare Fund Regular - Idcw performed recently?
- 3 Months: 0.19%
- 6 Months: 16.57%
What is the long-term performance of Quant Healthcare Fund Regular - Idcw?
- Since Inception: 22.08%
What is the portfolio composition of Quant Healthcare Fund Regular - Idcw?
Equity: 97.45%, Debt: 6.21%, Others: -3.65%.
Who manages Quant Healthcare Fund Regular - Idcw?
Quant Healthcare Fund Regular - Idcw is managed by Ankit A Pande from Quant Mutual Fund.
What is the market-cap allocation of Quant Healthcare Fund Regular - Idcw?
Large Cap: 20.31%, Mid Cap: 19.53%, Small Cap: 60.16%.
Which are the top companies Quant Healthcare Fund Regular - Idcw has invested in?
- Repo – 15.82% of the fund's portfolio
- Repo – 15.82% of the fund's portfolio
- Repo – 13.61% of the fund's portfolio
- Repo – 11.42% of the fund's portfolio
- Aster DM Healthcare Ltd – 10.01% of the fund's portfolio
Which are the major sectors Quant Healthcare Fund Regular - Idcw focuses on?
- Healthcare – 325.06% of the fund's portfolio
- Financial – 32.64% of the fund's portfolio
- Consumer Staples – 30.04% of the fund's portfolio
- Materials – 12.28% of the fund's portfolio
- Real Estate – 5.60% of the fund's portfolio
Policybazaar does not endorse rates/returns or recommend any particular insurer, fund house, AMC (Asset Management Company), insurance and mutual fund product.
Please consult your financial advisor for an informed decision.
Past performance may not be indicative of future results.
The information presented on this page is not owned or generated by Policybazaar. The data has been collected from publicly available sources and online research. We do not claim any ownership or guarantee the accuracy, completeness, or timeliness of this information. It is shared solely for the informational purpose of the viewer and should not be considered as financial advice.
Policybazaar is not acting as a financial advisor, broker, or agent for any mutual fund mentioned here.
Mutual fund investments are subject to market risks. Please read all scheme-related documents carefully before investing.
Policybazaar shall not be held responsible or liable for any losses, damages, or decisions made based on the information provided on this page.
For a complete list of mutual funds registered in India, please refer to the Securities and Exchange Board of India (SEBI) website at www.sebi.gov.in. We do not sell, endorse, or recommend any mutual fund or investment product. For a complete list of mutual funds registered in India, please refer to the Securities and Exchange Board of India (SEBI) website at www.sebi.gov.in. We do not sell, endorse, or recommend any mutual fund or investment product.
For more details on risk factors, terms, and conditions, please read the sales brochure and benefit illustration carefully before concluding a sale.
Policybazaar is a registered Insurance Broker | Registration No. 742, Registration Code No. IRDA/ DB 797/ 19, Valid till 09/06/2024, License category- Direct Broker (Life & General) |CIN: U74999HR2014PTC053454 | Registered Office - Plot No.119, Sector - 44, Gurgaon, Haryana – 122001 |Visitors are hereby informed that their information submitted on the website may be shared with insurers. Product information is authentic and solely based on the information received from the insurers.©️ Copyright 2008-2025 policybazaar.com. All Rights Reserved
^Returns as on 10th Jan’25. Tata AIA Life Top 200 ULIP Fund has delivered 18% returns over the last 10 years. Past performance is not necessarily indicative of future results. This disclaimer is specifically regarding a ULIP fund and is not related to mutual funds. Source: Morningstar.


